In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
MSK radiation oncologist and head and neck specialist Dr. Nadeem Riaz.
Article
Treatment for Head and Neck Squamous Cell Carcinoma Affected by Bacteria Inside the Tumors

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.
A researcher working in an MSK lab
MSK Research Highlights, September 25, 2025

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.
A hand holds a multichannel pipette above a well plate
Gerstner Sloan Kettering Graduate Students Receive 2025-2026 Fellowships

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Three syringes stuck into an orange and white bull’s-eye
In the Clinic
Drug Targeting Genetic Mutation Works across All Tumor Types

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.
MSK internal medicine specialist Deborah Korenstein
Q&A
Helping Doctors "Do No Harm" by Addressing Medical Test Overuse

Learn how MSK is clarifying how unnecessary medical tests can harm a patient's well-being.
Dr. Michael Overholtzer speaks to students.
Meet the 2024 Graduates of the Gerstner Sloan Kettering Graduate School

Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.
Colorful illustration of people overlaid on a world map
Finding
Genetic Variations Help Explain Why Immunotherapy Works Differently in Different People

A new study reports a possible way to quantify how efficient the immune system is at detecting cancer, and therefore how likely it is that a person will respond to immunotherapy.
Radiation oncologist and CyberKnife expert Abraham Wu
Ask the Expert
Why Am I Hearing So Much About CyberKnife?

CyberKnife is a brand name for one of several available stereotactic radiosurgery devices that deliver radiation with linear accelerators. MSK uses a similar device, made by a company called Varian, that destroys tumors with extremely precise, very intense doses of radiation.
Reicy Bobadilla stands in front of a window with the MSK logo on it
What You Should Know About Mesothelioma in Younger Patients

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.